Prof Tan Chee Kiat

MBBS (S'pore), MRCP (UK), FRCP (Edin), FAMS, FAASLD, PGDip MedEd (Dundee)

Senior Consultant

Specialty/Department: Gastroenterology ＆ Hepatology

Clinical Interest: Hepatology, Liver Cancer, Liver Transplantation, Viral Hepatitis

Conditions Treated by this Doctor:
Abnormal Liver Tests, Autoimmune Hepatitis, Fatty Liver Diseases, Hepatitis B, Hepatitis C, Liver Cancer (Hepatocellular Carcinoma), Liver Cirrhosis, Liver Fibrosis, Liver Transplant, Liver Transplantation, Metabolic Liver Disease, Non-alcoholic Steatohepatitis (NASH), Viral Hepatitis.

Make an Appointment

Clinical Appointments

Senior Consultant Gastroenterology ＆ Hepatology Singapore General Hospital

Academic Appointments

Clinical Professor, Duke-NUS Medical School
Clinical Associate Professor, Yong Loo Lin School of Medicine
Adjunct Associate Professor, Lee Kong Chian School of Medicine

Profile

Prof Tan Chee Kiat graduated from the Faculty of Medicine, National University of Singapore in 1984. He became a Member of the Royal College of Physicians, United Kingdom [MRCP (UK)] in 1989… View More +

Education

MBBS (S'pore)
MRCP (UK)
FRCP (Edin)
FAMS
FAASLD
PGDip MedEd (Dundee)

View More +

Awards

Singapore Cancer Syndicate Grant for development of National Liver Cancer Registry (2004-2009)
SGH Excellent Publication Award 2003
Glaxo Research Institute Fellow's Award for basic research 1994
Ministry of Health Manpower Development Program award 1993-1994
Singapore Government Local Merit Scholarship for Medicine (1979-1984)

Publications

TT Chang, CL Lai, S Han, KH Han, S Gordon, YC Chao, CK Tan, et al. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histologic damage. Hepatology (in press).
S Purushotham, PEJ Chang, H Rumpel, IHC Kee, RTH Ng, PKH Chow, CK Tan, RV Ramanujan. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 2009; 20: 305101. doi:10.1088/09574484/20/30/305101, published 7 July 2009.
PE Chang, WC Ong, HF Lui, CK Tan. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 2008; 43:881-888.
PE Chang, HF Lui, YP Chau, KH Lim, WM Yap, CK Tan, WC Chow. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminases platelet ratio index. Aliment Pharmacol Ther 2008; 28:51-61.
Tan CK, Law NM, Ng HS, Machin D. A simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. J Clin Oncol 2003; 21(12):2294-2298.
Chow PKH, Tai BC, Tan CK, et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized trial. Hepatology 2002; 36(5):1221-1226.
Tan CK, Ho MSJ. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl 2001; 7(5):461-465.
Tan CK, PKH Chow, Findlay M, et al. The use of tamoxifen in hepatocellular carcinoma – A review and paradigm shift. J Gastroenterol Hepatol 2000; 15(7): 725-9.
Tan CK, PV Podila, JE Taylor, et al. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology 1995; 108(6): 1908-16.
Tan CK, Gores GJ, Steers JL, et al. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc 1994; 69: 509-14.

View More +